KMT2A and leukemia: Largely due to the discovery of the translocations of KMT2A-producing fusion proteins in 70% of infant leukaemias and 10% of adult leukaemias [63,64], concentrated efforts have been applied to understanding the function of KMT2A in leukemogenesis.